CAS: 1260907-17-2 - GSK525762

Formel: C₂₂H₂₂ClN₅O₂

InChl: InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1

InChI Key: InChIKey=AAAQFGUYHFJNHI-SFHVURJKSA-N

SMILES: O=C(NCC)CC1N=C(C=2C=CC(Cl)=CC2)C=3C=C(OC)C=CC3N4C(=NN=C41)C

4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-, (4S)-

CAS: 1260907-17-2

• Formel: C₂₂H₂₂ClN₅O₂
• Reinheit: 98+%
• Farbe und Form: Solid
• Molekulargewicht: 423.8954

Molibresib

CAS: 1260907-17-2

Molibresib (GSK525762) is an inhibitor of BET proteins (IC50: about 35 nM).

• Formel: C₂₂H₂₂ClN₅O₂
• Reinheit: 99.08%
• Farbe und Form: Solid
• Molekulargewicht: 423.9

I-BET762

CAS: 1260907-17-2

GSK 525762A

CAS: 1260907-17-2

Applications GSK 525762A, is a BET Bromodomain Inhibitor, which is now in clinical development. BET …

• Formel: C₂₂H₂₂ClN₅O₂
• Farbe und Form: Neat
• Molekulargewicht: 423.9

GSK 525762A-d5

CAS: 1260907-17-2

• Formel: C₂₂D₅H₁₇ClN₅O₂
• Farbe und Form: Neat
• Molekulargewicht: 428.926

I-BET 762

CAS: 1260907-17-2

Inhibitor of BET bromodomain

• Formel: C₂₂H₂₂ClN₅O₂
• Reinheit: Min. 95%
• Molekulargewicht: 423.9 g/mol